339 related articles for article (PubMed ID: 30622177)
1. Inhibition of chemotherapy resistant breast cancer stem cells by a ROR1 specific antibody.
Zhang S; Zhang H; Ghia EM; Huang J; Wu L; Zhang J; Lam S; Lei Y; He J; Cui B; Widhopf GF; Yu J; Schwab R; Messer K; Jiang W; Parker BA; Carson DA; Kipps TJ
Proc Natl Acad Sci U S A; 2019 Jan; 116(4):1370-1377. PubMed ID: 30622177
[TBL] [Abstract][Full Text] [Related]
2. Molecular Mechanisms Associated with ROR1-Mediated Drug Resistance: Crosstalk with Hippo-YAP/TAZ and BMI-1 Pathways.
Karvonen H; Barker H; Kaleva L; Niininen W; Ungureanu D
Cells; 2019 Aug; 8(8):. PubMed ID: 31382410
[TBL] [Abstract][Full Text] [Related]
3. Antibody-drug conjugate T-DM1 treatment for HER2+ breast cancer induces ROR1 and confers resistance through activation of Hippo transcriptional coactivator YAP1.
Islam SS; Uddin M; Noman ASM; Akter H; Dity NJ; Basiruzzman M; Uddin F; Ahsan J; Annoor S; Alaiya AA; Al-Alwan M; Yeger H; Farhat WA
EBioMedicine; 2019 May; 43():211-224. PubMed ID: 31085100
[TBL] [Abstract][Full Text] [Related]
4. Ovarian cancer stem cells express ROR1, which can be targeted for anti-cancer-stem-cell therapy.
Zhang S; Cui B; Lai H; Liu G; Ghia EM; Widhopf GF; Zhang Z; Wu CC; Chen L; Wu R; Schwab R; Carson DA; Kipps TJ
Proc Natl Acad Sci U S A; 2014 Dec; 111(48):17266-71. PubMed ID: 25411317
[TBL] [Abstract][Full Text] [Related]
5. The Hedgehog signalling pathway mediates drug response of MCF-7 mammosphere cells in breast cancer patients.
He M; Fu Y; Yan Y; Xiao Q; Wu H; Yao W; Zhao H; Zhao L; Jiang Q; Yu Z; Jin F; Mi X; Wang E; Cui Z; Fu L; Chen J; Wei M
Clin Sci (Lond); 2015 Nov; 129(9):809-22. PubMed ID: 26201092
[TBL] [Abstract][Full Text] [Related]
6. ROR1 Expression and Its Functional Significance in Hepatocellular Carcinoma Cells.
Cetin M; Odabas G; Douglas LR; Duriez PJ; Balcik-Ercin P; Yalim-Camci I; Sayan AE; Yagci T
Cells; 2019 Mar; 8(3):. PubMed ID: 30832318
[TBL] [Abstract][Full Text] [Related]
7. Phase I Trial: Cirmtuzumab Inhibits ROR1 Signaling and Stemness Signatures in Patients with Chronic Lymphocytic Leukemia.
Choi MY; Widhopf GF; Ghia EM; Kidwell RL; Hasan MK; Yu J; Rassenti LZ; Chen L; Chen Y; Pittman E; Pu M; Messer K; Prussak CE; Castro JE; Jamieson C; Kipps TJ
Cell Stem Cell; 2018 Jun; 22(6):951-959.e3. PubMed ID: 29859176
[TBL] [Abstract][Full Text] [Related]
8. Twist promotes tumor metastasis in basal-like breast cancer by transcriptionally upregulating ROR1.
Cao J; Wang X; Dai T; Wu Y; Zhang M; Cao R; Zhang R; Wang G; Jiang R; Zhou BP; Shi J; Kang T
Theranostics; 2018; 8(10):2739-2751. PubMed ID: 29774072
[No Abstract] [Full Text] [Related]
9. DLG5 suppresses breast cancer stem cell-like characteristics to restore tamoxifen sensitivity by inhibiting TAZ expression.
Liu J; Li J; Li P; Jiang Y; Chen H; Wang R; Cao F; Liu P
J Cell Mol Med; 2019 Jan; 23(1):512-521. PubMed ID: 30450766
[TBL] [Abstract][Full Text] [Related]
10. Glucocorticoids induce differentiation and chemoresistance in ovarian cancer by promoting ROR1-mediated stemness.
Karvonen H; Arjama M; Kaleva L; Niininen W; Barker H; Koivisto-Korander R; Tapper J; Pakarinen P; Lassus H; Loukovaara M; Bützow R; Kallioniemi O; Murumägi A; Ungureanu D
Cell Death Dis; 2020 Sep; 11(9):790. PubMed ID: 32989221
[TBL] [Abstract][Full Text] [Related]
11. Targeting ROR1 inhibits epithelial-mesenchymal transition and metastasis.
Cui B; Zhang S; Chen L; Yu J; Widhopf GF; Fecteau JF; Rassenti LZ; Kipps TJ
Cancer Res; 2013 Jun; 73(12):3649-60. PubMed ID: 23771907
[TBL] [Abstract][Full Text] [Related]
12. Targeting ROR1 inhibits the self-renewal and invasive ability of glioblastoma stem cells.
Jung EH; Lee HN; Han GY; Kim MJ; Kim CW
Cell Biochem Funct; 2016 Apr; 34(3):149-57. PubMed ID: 26923195
[TBL] [Abstract][Full Text] [Related]
13. ROR1 is expressed in human breast cancer and associated with enhanced tumor-cell growth.
Zhang S; Chen L; Cui B; Chuang HY; Yu J; Wang-Rodriguez J; Tang L; Chen G; Basak GW; Kipps TJ
PLoS One; 2012; 7(3):e31127. PubMed ID: 22403610
[TBL] [Abstract][Full Text] [Related]
14. TGF-β inhibition enhances chemotherapy action against triple-negative breast cancer.
Bhola NE; Balko JM; Dugger TC; Kuba MG; Sánchez V; Sanders M; Stanford J; Cook RS; Arteaga CL
J Clin Invest; 2013 Mar; 123(3):1348-58. PubMed ID: 23391723
[TBL] [Abstract][Full Text] [Related]
15. ROR1 regulates chemoresistance in Breast Cancer via modulation of drug efflux pump ABCB1.
Fultang N; Illendula A; Lin J; Pandey MK; Klase Z; Peethambaran B
Sci Rep; 2020 Feb; 10(1):1821. PubMed ID: 32020017
[TBL] [Abstract][Full Text] [Related]
16. Targeting ROR1 identifies new treatment strategies in hematological cancers.
Karvonen H; Niininen W; Murumägi A; Ungureanu D
Biochem Soc Trans; 2017 Apr; 45(2):457-464. PubMed ID: 28408486
[TBL] [Abstract][Full Text] [Related]
17. A ROR1-HER3-lncRNA signalling axis modulates the Hippo-YAP pathway to regulate bone metastasis.
Li C; Wang S; Xing Z; Lin A; Liang K; Song J; Hu Q; Yao J; Chen Z; Park PK; Hawke DH; Zhou J; Zhou Y; Zhang S; Liang H; Hung MC; Gallick GE; Han L; Lin C; Yang L
Nat Cell Biol; 2017 Feb; 19(2):106-119. PubMed ID: 28114269
[TBL] [Abstract][Full Text] [Related]
18. Receptor tyrosine kinase-like orphan receptor 1, a target of NKX2-1/TTF-1 lineage-survival oncogene, inhibits apoptosis signal-regulating kinase 1-mediated pro-apoptotic signaling in lung adenocarcinoma.
Ida L; Yamaguchi T; Yanagisawa K; Kajino T; Shimada Y; Suzuki M; Takahashi T
Cancer Sci; 2016 Feb; 107(2):155-61. PubMed ID: 26661061
[TBL] [Abstract][Full Text] [Related]
19. YAP/BRD4-controlled ROR1 promotes tumor-initiating cells and hyperproliferation in pancreatic cancer.
Yamazaki M; Hino S; Usuki S; Miyazaki Y; Oda T; Nakao M; Ito T; Yamagata K
EMBO J; 2023 Jul; 42(14):e112614. PubMed ID: 37096681
[TBL] [Abstract][Full Text] [Related]
20. Wnt5a induces ROR1/ROR2 heterooligomerization to enhance leukemia chemotaxis and proliferation.
Yu J; Chen L; Cui B; Widhopf GF; Shen Z; Wu R; Zhang L; Zhang S; Briggs SP; Kipps TJ
J Clin Invest; 2016 Feb; 126(2):585-98. PubMed ID: 26690702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
